Companies: 10,795·Total market cap: $144.5T
Guided Therapeutics, Inc.

Guided Therapeutics, Inc.

GTHPOTCHealthcare● Active
$0.20
$-0.03(-12.28%)
Market Cap$15340000
P/E Ratio
52W High$0.54
52W Low$0.123
Overview

Guided Therapeutics, Inc. (GTHP) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · GTHP · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-0.04gthp eps ttm · gthp earnings per shareEarnings history
PE Ratio (TTM)gthp pe ratio ttm · gthp price to earningsPE Ratio deep dive
Revenue (TTM)767000.00gthp revenue ttm · gthp annual revenueFull revenue history
Dividend YieldNo Dividenddoes gthp pay dividends · gthp dividend yieldDividend history
Shares Outstanding78.4Mgthp shares outstanding · gthp floatShares outstanding history
Next EarningsTBAgthp earnings date · gthp next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$767000.00▲ +10857.14% YoY
202320242025
guided therapeutics, inc. revenue · gthp revenue 2025
FY 2025Net Income-$3.2M▼ 32.23% YoY
202320242025
guided therapeutics, inc. net income · gthp profit 2025
FY 2025EPS$-0.04▲ +5.53% YoY
202320242025
gthp eps · guided therapeutics, inc. earnings per share 2025
TTM:Revenue: $767000.00Net Income: -$3.9MEPS: $-0.04View income statement →

Stock Performance

Full History
1D-12.28%
1W-12.28%
1M+0.00%
3M-33.33%
YTD-62.96%
1Y+14.29%
5Y-69.23%

About Guided Therapeutics, Inc.

CEOMark L. Faupel
IPO DateJan 8, 2021
Employees4
CountryUS

Guided Therapeutics, Inc. is a medical technology firm specializing in the creation of medical devices. Its primary focus is on bringing to market LuViva, an innovative device designed for the non-inv…

what is guided therapeutics, inc. · gthp stock overview · guided therapeutics, inc. company profile · who is guided therapeutics, inc. ceo · gthp OTC · guided therapeutics, inc. headquarters · guided therapeutics, inc. business segments

About Stock Overview & Key Data

Guided Therapeutics, Inc. (GTHP) is a Healthcare company in the Medical - Devices industry, listed on OTC since Jan 8, 2021. As of the latest trading session, GTHP stock price is $0.20, with a market capitalization of $15.3M. The stock has returned +14.29% over the past 12 months and -62.96% year-to-date.

In fiscal year 2025, Guided Therapeutics, Inc. reported revenue of $767000.00. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Guided Therapeutics, Inc. (GTHP) stock price is $0.20. The stock is traded on OTC under the ticker symbol GTHP. The 52-week range is $0.12 – $0.54.

GTHP stock priceGTHP quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice